Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Talk:Bioblast 2022"

From Bioblast
Line 30: Line 30:
|-
|-
|  || Molecular, kinetic, and thermodynamic advances in bioenergetics || 11:30-11:45||  || [[Komlodi Timea]]
|  || Molecular, kinetic, and thermodynamic advances in bioenergetics || 11:30-11:45||  || [[Komlodi Timea]]
|-
|-
|  || Molecular, kinetic, and thermodynamic advances in bioenergetics || 11:45-12:00 || ||
|-
|-
|-
|-
Line 35: Line 38:
|-
|-
|-
|-
|  || Molecular, kinetic, and thermodynamic advances in bioenergetics || 12:15-12:30 || ||
|  || Molecular, kinetic, and thermodynamic advances in bioenergetics || 12:15-12:20 || ||
|-
|-
|  || Molecular, kinetic, and thermodynamic advances in bioenergetics || 12:20-12:25 ||  ||  
|-
|-
|-
|-
|  || Molecular, kinetic, and thermodynamic advances in bioenergetics || 11:45-12:00 ||  ||  
|  || Molecular, kinetic, and thermodynamic advances in bioenergetics || 12:20-12:30 ||  |
|-
|-
|-
|-
Line 56: Line 62:
|-
|-
|-
|-
|  || Perspectives of bioenergetics in health and disease || 14:45  - 15:00 || ||  
|  || Perspectives of bioenergetics in health and disease || 14:45  - 15:00 || ::::## [[Neuzil Jiri|Metabolic switch utilizing ammonia supports proliferation in regenerating liver]] || [[Neuzil Jiri]]
|-
|-
|-
|-
Line 71: Line 77:
|-
|-
|-
|-
|  || Perspectives of bioenergetics in health and disease II || 16:15  - 16:30 ||  ||  
|  || Perspectives of bioenergetics in health and disease II || 16:15  - 16:30 || [[Chakrabarti Sasanka |Rotenone cytotoxicity on SH-SY5Y cells: role of ferroptosis, mitochondria and alpha-synuclein]] || [[Chakrabarti Sasanka]]
|-
|-
|  || Perspectives of bioenergetics in health and disease II || 16:30 - 16:35 || ||
|-
|-
|-
|  || Perspectives of bioenergetics in health and disease II || 16:35  - 16:40 || ||
|-
|-
|  || Perspectives of bioenergetics in health and disease II || 16:30 - 16:45 || ||
|-
|  || Perspectives of bioenergetics in health and disease II || 16:40 - 16:45 || ||
|-
|-
|-
|-
Line 93: Line 105:
|-
|-
|-
|-
|  || Mitochondrial pharmacology || 09:15  - 09:30 || ||   
|  || Mitochondrial pharmacology || 09:15  - 09:30 || [[Koopman_Werner_JH |The decylTPP mitochondria-targeting moiety lowers electron transport chain supercomplex levels in primary human skin fibroblasts]] ||  [[Koopman_Werner_JH]]
|-
|-
|  || Mitochondrial pharmacology || 09:30  - 09:45 ||  [https://abliva.com/company/ Towards a treatment for mitochondrial disease: Current compounds in clinical development] ||
|-
|-
|  || Mitochondrial pharmacology || 09:45 - 10:00 || || [[Dambrova Maija]]
|-
|-
|-
|-
|  || Mitochondrial pharmacology || 09:30 - 09:45 || Physiometabolic RTCA on an automated platform for short and long term applications || Peter Wolf (Incyton)
|  || Mitochondrial pharmacology || 10:00 - 10:20 || [[MitoKIN |Kinase perturbations redirect mitochondrial function]] || [[Torres-Quesada Omar]]
|-
|-
|-
|-
|  || Mitochondrial pharmacology || 09:45 - 10:00 || [[Posch 2022 MitoFit |How to optimize respiratory models for SARS-CoV-2 research]] || Doris Wilfingseder
|  || Mitochondrial pharmacology ||  ||  || [[Eduard Stefan]]
|-
|-
|-
|-
|  || Mitochondrial pharmacology || 10:00 - 10:15 || [[Baglivo Eleonora|Statistical analysis of instrumental reproducibility as internal quality control in high-resolution respirometry]] || [[Baglivo Eleonora]]
|  || Mitochondrial pharmacology || 10:20 - 10:35 || [[Chicco Adam J |Resolving the Rotenone Paradox: elucidating the Complexity of multi-substrate respirometry protocols]]|| [[Chicco Adam J]]
|-
|-
|-
|-
|  || Mitochondrial pharmacology || 10:00 - 10:30 || [[Chicco Adam J |Resolving the Rotenone Paradox: elucidating the Complexity of multi-substrate respirometry protocols]]|| [[Chicco Adam J]]
|  '''10:35 - 11:00''' || '''Poster session''' || || ||  
|-
|-
|-
|-

Revision as of 18:49, 17 May 2022

Program

2022-06-29 Day 1 of scientific presentations

Time (CET) Topic Time per lecture Title Speaker
09:15-09:45 Opening speech Gnaiger Erich
09:45-11:00 Scientific Session I
Evolutionary perspectives of bioenergetics 09:45 - 10:15 Opening Lecture: The alpha and omega of metabolism: why the Krebs cycle brings the earth to life and our own lives to an end Lane Nick
Evolutionary perspectives of bioenergetics 10:15 - 10:30 Bioblasts - the taxonomic unit of bioenergetics: mitochondria, chloroplasts, aerobic bacteria Gnaiger Erich
Algal bioenergetics 10:30 - 10:45 Oxidative stress in photosynthesis Roach Thomas
Algal bioenergetics 10:00 - 10:30 Photosynthetic capacity under oscillating light regimes Morosinotto Tomas
11:00-11:30 Coffee Break
11:30-12:30 Scientific Session II
Molecular, kinetic, and thermodynamic advances in bioenergetics 11:30-11:45 Komlodi Timea
Molecular, kinetic, and thermodynamic advances in bioenergetics 11:45-12:00
Molecular, kinetic, and thermodynamic advances in bioenergetics 12:00-12:15 Resolving the Rotenone Paradox: elucidating the Complexity of multi-substrate respirometry protocols Chicco Adam J
Molecular, kinetic, and thermodynamic advances in bioenergetics 12:15-12:20
Molecular, kinetic, and thermodynamic advances in bioenergetics 12:20-12:25
Molecular, kinetic, and thermodynamic advances in bioenergetics 12:20-12:30
12:30-14:00 Lunch Break
14:00-15:30 Scientific Session III
Perspectives of bioenergetics in health and disease 14:00 - 14:15
Perspectives of bioenergetics in health and disease 14:15 - 14:30 Estimation of energy pathway fluxes in cancer cells- beyond the Warburg effect MX Mexiko City Moreno-Sanchez R
Perspectives of bioenergetics in health and disease 14:30 - 14:45
Perspectives of bioenergetics in health and disease 14:45 - 15:00 ::::## Metabolic switch utilizing ammonia supports proliferation in regenerating liver Neuzil Jiri
15:00 - 15:30 Poster flashes or guided tour
15:30 - 16:00 Coffee Break
16:00-17:15 Scientific Session IV
Perspectives of bioenergetics in health and disease II 16:00 - 16:15 NUBPL: a mitochondrial Complex I deficiency disorder Stiban Johnny
Perspectives of bioenergetics in health and disease II 16:15 - 16:30 Rotenone cytotoxicity on SH-SY5Y cells: role of ferroptosis, mitochondria and alpha-synuclein Chakrabarti Sasanka
Perspectives of bioenergetics in health and disease II 16:30 - 16:35
Perspectives of bioenergetics in health and disease II 16:35 - 16:40
Perspectives of bioenergetics in health and disease II 16:40 - 16:45
Perspectives of bioenergetics in health and disease II 16:45 - 17:00
Perspectives of bioenergetics in health and disease 17:00 - 17:15 Effects of eye-movement desensitization and reprocessing (EMDR) therapy on mitochondrial bioenergetics in immune cells from patients with post-traumatic stress disorder (PTSD): a pilot study Karabatsiakis Alexander


2022-06-30 Day 2 of scientific presentations

Time (CET) Type of speech Time per lecture Title Speaker
09:15 - 10:30 Scientific Session I
Mitochondrial pharmacology 09:15 - 09:30 The decylTPP mitochondria-targeting moiety lowers electron transport chain supercomplex levels in primary human skin fibroblasts Koopman_Werner_JH
Mitochondrial pharmacology 09:30 - 09:45 Towards a treatment for mitochondrial disease: Current compounds in clinical development
Mitochondrial pharmacology 09:45 - 10:00 Dambrova Maija
Mitochondrial pharmacology 10:00 - 10:20 Kinase perturbations redirect mitochondrial function Torres-Quesada Omar
Mitochondrial pharmacology Eduard Stefan
Mitochondrial pharmacology 10:20 - 10:35 Resolving the Rotenone Paradox: elucidating the Complexity of multi-substrate respirometry protocols Chicco Adam J
10:35 - 11:00 Poster session
11:00 - 11:30 Coffee Break
11:30 - 12:30 Scientific Session II
Methodological advancements in bioenergetics 11:30 - 11:45 Contextual Tissue Cytometry with AI – Functional Single Cell Analyses in-situ Ecker Rupert
Methodological advancements in bioenergetics 11:45 - 12:00 Physiometabolic RTCA on an automated platform for short and long term applications Wolf Peter
Methodological advancements in bioenergetics 12:00 - 12:15
Methodological advancements in bioenergetics 12:15 - 12:30
12:30 - 14:00 Lunch Break
14:00-15:30 Scientific Session III
Methodological advancements in bioenergetics II 14:00 - 14:15 Redox monitoring and respiration - a new horizon with the NextGen-O2k Cardoso Luiza HD
Methodological advancements in bioenergetics II 14:15 - 14:30 Tuning the assessment of coenzyme Q redox state and respiration in skeletal muscle permeabilized fibers Garcia-Roves Pablo Miguel
Methodological advancements in bioenergetics II 14:30 - 14:45 Mitochondrial calcium uptake capacity is lower than calcium retention capacity in the presence and absence of cyclosporin A Cecatto Cristiane
Methodological advancements in bioenergetics II 14:45 - 15:00
Methodological advancements in bioenergetics II 15:00 - 15:15
Methodological advancements in bioenergetics II 15:15 - 15:30
15:30 - 16:00 Coffee Break
16:00-17:30 Scientific Session IV
16:00 - 16:15
16:15 - 16:30
16:30 - 16:45
16:45 - 17:00
17:00 - 17:15
17:15 - 17:30
Retrieved from "https://wiki.oroboros.at/index.php?title=Talk:Bioblast_2022&oldid=227265"
Powered by MediaWiki
Powered by Semantic MediaWiki